But Cabot is not daunted by its site, which is still a shell of a building. As GlobeSt.com reported last month, the company is looking to the biotechnology industry to fill its space. Sources from the Massachusetts Biotechnology Council had told GlobeSt.com that the building developers had been considering converting the building into biotech space to attract tenants from the biotech and pharmaceutical industries. Now, reportedly, Cabot is negotiating with two tenants who need biopharmaceutical manufacturing space and biotech lab and research space.
Converting the project from its approved plan to biotech space would require new city approvals, and probably additional parking spaces as well as major aesthetic changes. Reportedly Cabot would have to spend an additional $850,000 for local roads.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
